ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.477,62
-0,66%
S&P 500
5.649,24
0,32%
Dow Jones
40.534,22
0,80%
Euro vs US Dollar
1,08771
-0,21%
Bitcoin
63.823,69
-1,58%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. AstraZeneca PLC (AZN)

  7. AstraZeneca PLC (AZN) News

AZN

AstraZeneca (AZN)

AstraZeneca PLC
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:AZN
DatumZeitQuelleÜberschriftSymbolFirma
09/01/202313h43Dow Jones NewsCinCor Pharma Shares Take Flight on Takeover by AstraZenecaNASDAQ:AZNAstraZeneca PLC
09/01/202312h08Dow Jones NewsTrending: AstraZeneca in Focus After Buying CinCor Pharma for Baxdrostat Cardiorenal DrugNASDAQ:AZNAstraZeneca PLC
09/01/202308h49Dow Jones NewsAstraZeneca to Buy CinCor Pharma for Baxdrostat Cardiorenal DrugNASDAQ:AZNAstraZeneca PLC
06/01/202323h28Dow Jones NewsAstraZeneca's Evusheld Unlikely to Protect Against XBB.1.5 Subvariant, FDA SaysNASDAQ:AZNAstraZeneca PLC
05/01/202315h30Business WireTempus Announces Prospective Study for Biomarker Discovery in Small Cell Lung CancerNASDAQ:AZNAstraZeneca PLC
05/01/202308h55Dow Jones NewsSanofi, AstraZeneca Respiratory Treatment Nirsevimab Biologics License Accepted by FDANASDAQ:AZNAstraZeneca PLC
30/12/202213h13Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AZNAstraZeneca PLC
28/12/202223h07Dow Jones NewsADRs End Mostly Lower, AstraZeneca and ABB Trade ActivelyNASDAQ:AZNAstraZeneca PLC
28/12/202212h44Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AZNAstraZeneca PLC
28/12/202212h26Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AZNAstraZeneca PLC
22/12/202200h37Dow Jones NewsADRs End Higher, AstraZeneca and Carnival Trade ActivelyNASDAQ:AZNAstraZeneca PLC
21/12/202212h37Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AZNAstraZeneca PLC
21/12/202212h23Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AZNAstraZeneca PLC
20/12/202200h38Dow Jones NewsADRs End Mixed; AstraZeneca, atai Life Sciences Trade ActivelyNASDAQ:AZNAstraZeneca PLC
20/12/202200h26ValueWalkEli Lilly Expects Enduring Growth, Despite Immediate ChallengesNASDAQ:AZNAstraZeneca PLC
19/12/202214h49Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AZNAstraZeneca PLC
19/12/202214h24Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AZNAstraZeneca PLC
19/12/202213h05Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AZNAstraZeneca PLC
19/12/202212h43Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AZNAstraZeneca PLC
19/12/202208h55Dow Jones NewsAstraZeneca's Imfinzi Plus Imjudo Recommended for Approval in the EUNASDAQ:AZNAstraZeneca PLC
19/12/202208h46Dow Jones NewsAstraZeneca's Forxiga Recommended for EU Approval for Symptomatic Chronic Heart FailureNASDAQ:AZNAstraZeneca PLC
15/12/202213h30Dow Jones NewsMerck, AstraZeneca Receive FDA Extension on Lynparza New Drug Application DateNASDAQ:AZNAstraZeneca PLC
15/12/202212h42Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AZNAstraZeneca PLC
13/12/202216h02Business WireAstraZeneca Awards $4M to Nonprofit Organizations to Advance Health EquityNASDAQ:AZNAstraZeneca PLC
09/12/202223h52Dow Jones NewsADRs End Lower; AstraZeneca, British American Tobacco Trade ActivelyNASDAQ:AZNAstraZeneca PLC
08/12/202214h35Business WireCamizestrant Significantly Delayed Disease Progression in Advanced ER-Positive Breast Cancer, Adding at Least 3.5 Months Benefit Versus FASLODEX® (fulvestrant)NASDAQ:AZNAstraZeneca PLC
08/12/202214h30Business WireCapivasertib Plus FASLODEX® (fulvestrant) Reduced the Risk of Disease Progression or Death by 40% Versus FASLODEX in Advanced HR-Positive Breast CancerNASDAQ:AZNAstraZeneca PLC
07/12/202214h30Business WireENHERTU® (fam-trastuzumab deruxtecan-nxki) Achieved Statistically Significant Overall Survival, Reducing the Risk of Death by 36% Vs. Trastuzumab Emtansine (T-DM1) in Patients With HER2-positive Metastatic Breast cancer in DESTINY-Breast03NASDAQ:AZNAstraZeneca PLC
30/11/202213h00Business WireAstraZeneca Showcases Strength of Hematology Portfolio and Pipeline Across Multiple Hard-to-Treat Conditions at ASH 2022NASDAQ:AZNAstraZeneca PLC
29/11/202208h53Dow Jones NewsAstraZeneca to Buy Neogene Therapeutics for $320 MillionNASDAQ:AZNAstraZeneca PLC
 Showing the most relevant articles for your search:NASDAQ:AZN

Kürzlich von Ihnen besucht

NASDAQ
BYND
Beyond Meat
NYSE
DRII
DIAMOND RESORTS INTERNATIONAL, I
NASDAQ
SMMT
Summit Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten